Monocytes and macrophages express CD4 on their surface and are targets for HIV. Infection of phagocytic cells is not cytotoxic, and these chronically infected cells may serve as a reservoir for HIV. Continued characterization of the functional abnormalities of this population is essential to understanding the immunosuppressed state of AIDS patients. Recent studies have demonstrated that HIV infection induces production of a cytokine unique to monocytes and macrophages: the interleukin-1 receptor antagonist (IL-1ra). This cytokine is secreted by activated phagocytes, binds to the IL-1 receptor, but does not transduce a signal. IL-1ra is unique in that it is the only known endogenous receptor antagonist. By binding to the IL-1 receptor, IL-1ra attenuates the pro- inflammatory actions of IL-1. Monocytes produce both IL-1 and IL-1ra, and the relationship between these two cytokines is crucial to maintaining the proper balance between immune cell recruitment/activation and immunosuppression and tissue repair. In addition to influencing immune status, infected monocytes serve as a reservoir for HIV-1 favoring selective therapeutic targeting of this population. Interaction of HIV-1 with cell surface CD4 transduces a signal inducing secretion of cytokines, and also de novo expression of activation antigens. For example, monocytes from HIV+ individuals maybe CD16+ and IL-2R+ in contrast to monocytes from control subjects. The emergence of IL-2R on infected cells provides the basis for targeted toxins. Current studies are focusing on other alterations in the expression of antigens and surface receptors as selective toxin targets for therapeutic intervention.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Intramural Research (Z01)
Project #
1Z01DE000513-04
Application #
3775698
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
1993
Total Cost
Indirect Cost
Name
National Institute of Dental & Craniofacial Research
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Greenwell-Wild, Teresa; Vazquez, Nancy; Jin, Wenwen et al. (2009) Interleukin-27 inhibition of HIV-1 involves an intermediate induction of type I interferon. Blood 114:1864-74
Mavragani, Clio P; Niewold, Timothy B; Moutsopoulos, Niki M et al. (2007) Augmented interferon-alpha pathway activation in patients with Sjogren's syndrome treated with etanercept. Arthritis Rheum 56:3995-4004
Peng, Gang; Greenwell-Wild, Teresa; Nares, Salvador et al. (2007) Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression. Blood 110:393-400
Moutsopoulos, Niki M; Nares, Salvador; Nikitakis, Nikolaos et al. (2007) Tonsil epithelial factors may influence oropharyngeal human immunodeficiency virus transmission. Am J Pathol 171:571-9
Peng, Gang; Lei, Ke Jian; Jin, Wenwen et al. (2006) Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity. J Exp Med 203:41-6
Moutsopoulos, N M; Greenwell-Wild, T; Wahl, S M (2006) Differential mucosal susceptibility in HIV-1 transmission and infection. Adv Dent Res 19:52-6
Vazquez, Nancy; Greenwell-Wild, Teresa; Rekka, Sofia et al. (2006) Mycobacterium avium-induced SOCS contributes to resistance to IFN-gamma-mediated mycobactericidal activity in human macrophages. J Leukoc Biol 80:1136-44
Wahl, Sharon M; Greenwell-Wild, Teresa; Vazquez, Nancy (2006) HIV accomplices and adversaries in macrophage infection. J Leukoc Biol 80:973-83
Riley, E M; Wahl, S; Perkins, D J et al. (2006) Regulating immunity to malaria. Parasite Immunol 28:35-49
Moutsopoulos, Niki M; Vazquez, Nancy; Greenwell-Wild, Teresa et al. (2006) Regulation of the tonsil cytokine milieu favors HIV susceptibility. J Leukoc Biol 80:1145-55

Showing the most recent 10 out of 21 publications